Apyx Medical Corp (APYX) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 9.35M USD | Liabilities, Current |
| Cash and equivalents | 27.62M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Customer receivables | 13.61M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 10.75M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $9.35M | $27.62M | (m) | $13.61M | $10.75M | (m) |
| 2026-03-31 | (m) | $9.45M | $31.14M | (m) | $12.76M | $9.54M | (m) |
| 2025-12-31 | (m) | $11.70M | $31.74M | (m) | $16.78M | $8.60M | (m) |
| 2025-09-30 | (m) | $10.98M | $25.14M | (m) | $12.99M | $9.14M | (m) |
| 2025-06-30 | (m) | $10.57M | $29.30M | (m) | $11.25M | $8.19M | (m) |
| 2025-03-31 | (m) | $9.51M | $31.01M | (m) | $11.64M | $7.68M | (m) |
| 2024-12-31 | (m) | $10.72M | $31.74M | (m) | $15.48M | $7.56M | (m) |
| 2024-09-30 | (m) | $9.55M | $28.01M | (m) | $13.04M | $9.00M | (m) |
| 2024-06-30 | (m) | $10.64M | $32.68M | (m) | $12.71M | $9.32M | (m) |
| 2024-03-31 | (m) | $10.56M | $37.28M | (m) | $12.49M | $9.79M | (m) |
| 2023-12-31 | (m) | $12.74M | $43.65M | (m) | $14.02M | $9.92M | (m) |
| 2023-09-30 | (m) | $10.29M | $22.13M | (m) | $12.65M | $11.29M | (m) |
| 2023-06-30 | (m) | $19.03M | $18.48M | (m) | $12.07M | $11.17M | (m) |
| 2023-03-31 | (m) | $18.53M | $16.25M | (m) | $9.97M | $10.95M | (m) |
| 2022-12-31 | (m) | $11.85M | $10.19M | (m) | $10.60M | $11.80M | (m) |
| 2022-09-30 | (m) | $11.19M | $14.83M | (m) | $9.09M | $12.04M | (m) |
| 2022-06-30 | (m) | $11.35M | $20.06M | (m) | $10.34M | $9.68M | (m) |
| 2022-03-31 | (m) | $11.60M | $26.23M | (m) | $12.36M | $7.02M | (m) |
| 2021-12-31 | (m) | $13.21M | $30.87M | (m) | $13.04M | $6.78M | (m) |
| 2021-09-30 | (m) | $11.71M | $30.90M | (m) | $11.44M | $6.04M | (m) |
| 2021-06-30 | (m) | $10.74M | $34.67M | (m) | $8.98M | $5.27M | (m) |
| 2021-03-31 | (m) | $9.73M | $39.54M | (m) | $7.68M | $4.46M | (m) |
| 2020-12-31 | $89.98M | $9.15M | $41.91M | $39.66M | $8.40M | $4.05M | 9.83× |
| 2020-09-30 | (m) | $9.59M | $43.54M | (m) | $6.15M | $5.42M | (m) |
| 2020-06-30 | (m) | $9.63M | $46.16M | (m) | $6.31M | $5.26M | (m) |
| 2020-03-31 | (m) | $10.60M | $51.38M | (m) | $6.12M | $5.87M | (m) |
| 2019-12-31 | $123.37M | $12.31M | $58.81M | $56.58M | $7.99M | $5.07M | 10.02× |
| 2019-09-30 | $130.93M | $9.04M | $62.27M | $61.00M | $7.66M | $7.24M | 14.49× |
| 2019-06-30 | (m) | $7.90M | $67.36M | (m) | $6.22M | $6.39M | (m) |
| 2019-03-31 | (m) | $7.47M | $32.41M | (m) | $4.93M | $5.60M | (m) |
| 2018-12-31 | (m) | $7.70M | $16.47M | (m) | $5.01M | $5.21M | (m) |
| 2018-09-30 | (m) | $21.67M | $40.66M | (m) | $4.08M | $6.04M | (m) |
| 2018-06-30 | (m) | $6.24M | $7.88M | (m) | $5.59M | $7.53M | (m) |
| 2018-03-31 | (m) | $5.69M | $8.70M | (m) | $5.14M | $6.71M | (m) |
| 2017-12-31 | (m) | $5.97M | $9.95M | (m) | $4.86M | $6.53M | (m) |
| 2017-09-30 | (m) | $4.81M | $9.41M | (m) | $4.08M | $7.33M | (m) |
| 2017-06-30 | (m) | $5.62M | $10.29M | (m) | $4.93M | $7.58M | (m) |
| 2017-03-31 | (m) | $4.93M | $11.51M | (m) | $4.28M | $7.42M | (m) |
| 2016-12-31 | (m) | $5.27M | $14.46M | (m) | $4.73M | $6.16M | (m) |
| 2016-09-30 | (m) | $4.22M | $9.33M | (m) | $3.87M | $5.93M | (m) |
| 2016-06-30 | (m) | $4.62M | $9.32M | (m) | $3.51M | $6.42M | (m) |
| 2016-03-31 | (m) | $7.21M | $9.46M | (m) | $3.14M | $6.56M | (m) |
| 2015-12-31 | (m) | $4.12M | $11.80M | (m) | $2.92M | $5.96M | (m) |
| 2015-09-30 | (m) | $4.66M | $13.20M | (m) | $2.52M | $6.13M | (m) |
| 2015-06-30 | (m) | $3.85M | $14.09M | (m) | $2.04M | $6.35M | (m) |
| 2015-03-31 | (m) | $4.08M | $15.40M | (m) | $1.40M | $6.13M | (m) |
| 2014-12-31 | (m) | $3.77M | $5.73M | (m) | $1.99M | $5.73M | (m) |
| 2014-09-30 | (m) | $3.12M | $6.13M | (m) | $2.04M | $6.48M | (m) |
| 2014-06-30 | (m) | $2.54M | $5.58M | (m) | $2.62M | $6.92M | (m) |
| 2014-03-31 | (m) | $2.42M | $5.82M | (m) | $2.23M | $8.27M | (m) |
| 2013-12-31 | (m) | $2.91M | $7.92M | (m) | $1.99M | $8.41M | (m) |
| 2013-09-30 | (m) | $3.17M | $2.50M | (m) | $2.10M | $8.53M | (m) |
| 2013-06-30 | (m) | $2.95M | $2.56M | (m) | $2.37M | $8.24M | (m) |
| 2013-03-31 | (m) | $2.16M | $3.76M | (m) | $1.93M | $8.54M | (m) |
| 2012-12-31 | (m) | $1.92M | $4.16M | (m) | $2.87M | $7.98M | (m) |
| 2012-09-30 | (m) | $1.93M | $4.49M | (m) | $2.64M | $7.78M | (m) |
| 2012-06-30 | (m) | $2.00M | $4.98M | (m) | $2.63M | $7.36M | (m) |
| 2012-03-31 | (m) | $2.00M | $4.12M | (m) | $2.56M | $8.04M | (m) |
| 2011-12-31 | (m) | $2.39M | $4.88M | (m) | $2.22M | $8.18M | (m) |
| 2011-09-30 | (m) | $1.95M | $5.41M | (m) | $2.18M | $7.66M | (m) |
| 2011-06-30 | (m) | $2.00M | $5.71M | (m) | $2.22M | $7.21M | (m) |
| 2011-03-31 | (m) | (m) | $4.45M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $1.80M | $3.83M | (m) | $2.11M | $7.61M | (m) |
| 2010-09-30 | (m) | (m) | $2.65M | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $3.37M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $2.15M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $2.56M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |